Oregon Translational Research Anddrug Development is categorized under Testing Laboratories in Portland, OR .
Oregon Translational Research Anddrug Development was established in 0, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 541380 by the NAICS.
If you are seeking more information, feel free to contact Alan Brickley at the company’s single location by writing to 9020 Sw Washington Square, Portland, Oregon OR 97223 or by phoning (616) 453-0730. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oregon Translational Research Anddrug Development |
| Contact Person: | Alan Brickley |
| Address: | 9020 Sw Washington Square, Portland, Oregon 97223 |
| Phone Number: | (616) 453-0730 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 541380 |
| Share This Business: |
Oregon Translational Research Anddrug Development was started in 0 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Alan Brickley for inquiries that concern Oregon Translational Research Anddrug Development by calling the company number (616) 453-0730, as your correspondence is most welcome. Additionally, the physical location of the single location of Oregon Translational Research Anddrug Development can be found at the coordinates as well as the street address 9020 Sw Washington Square in Portland, Oregon 97223.
For its online presence, you may visit Oregon Translational Research Anddrug Development’s website at and engage with its social media outlets through on Twitter and on Facebook.